Xlife Sciences AG (SWX:XLS)
Switzerland
· Delayed Price · Currency is CHF
22.50
-0.80 (-3.43%)
Last updated: Dec 5, 2025, 2:09 PM CET
Xlife Sciences AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 130 | 146 | 279 | 157 | - | - | |
| Market Cap Growth | -13.07% | -47.72% | 77.76% | - | - | - | |
| Enterprise Value | 277 | 295 | 434 | 321 | - | - | |
| Last Close Price | 22.50 | 25.40 | 49.90 | 29.70 | - | - | |
| PE Ratio | 4.95 | 4.26 | 18.75 | 10.97 | - | - | |
| PS Ratio | 154.60 | 174.69 | 282.22 | 152.66 | - | - | |
| PB Ratio | 0.33 | 0.37 | 0.76 | 0.47 | - | - | |
| P/TBV Ratio | 3.08 | 4.04 | - | - | - | - | |
| P/FCF Ratio | - | - | 1766.87 | - | - | - | |
| P/OCF Ratio | - | - | 1623.87 | - | - | - | |
| EV/Sales Ratio | - | 353.76 | 439.10 | 311.96 | - | - | |
| EV/FCF Ratio | -1158.88 | - | 2749.02 | - | - | - | |
| Debt / Equity Ratio | 0.15 | 0.15 | 0.16 | 0.18 | 0.20 | 0.40 | |
| Debt / FCF Ratio | - | - | 359.14 | - | - | - | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Quick Ratio | 1.07 | 1.53 | 3.11 | 0.61 | 1.05 | 1.60 | |
| Current Ratio | 1.08 | 1.54 | 3.11 | 0.65 | 1.06 | 1.61 | |
| Return on Equity (ROE) | 6.62% | 7.54% | 2.64% | 2.67% | 23.71% | 18.56% | |
| Return on Assets (ROA) | -2.33% | -2.30% | -2.53% | -2.70% | -0.98% | -1.14% | |
| Return on Capital (ROIC) | -2.79% | -2.76% | -3.09% | -3.36% | -1.16% | -1.15% | |
| Return on Capital Employed (ROCE) | -3.70% | -3.60% | -4.00% | -4.30% | -1.10% | -1.70% | |
| Earnings Yield | 23.70% | 23.50% | 5.33% | 9.12% | - | - | |
| FCF Yield | -0.18% | -0.30% | 0.06% | -2.95% | - | - | |
| Buyback Yield / Dilution | 20.65% | -1.34% | 0.17% | -17.26% | -4.77% | -60.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.